Management of osteoporosis in CKD doi.org/10.1093/ckj/... This Review summarises the current understanding of and recommendations for the diagnosis and management of osteoporosis in CKD and provides a pragmatic approach to fracture risk assessment and reduction in this population

Tolvaptan in autosomal dominant polycystic kidney disease: a multicenter real-life study doi.org/10.1093/ckj/...

Evidence of pancreatic iron deposits and their association with mortality in dialysis-associated iatrogenic hemosiderosis doi.org/10.1093/ckj/...

Pathways to translation for nanomedicine in nephrology doi.org/10.1093/ckj/...

Dosing, treatment patterns, and safety of finerenone use in routine care: an interim analysis of the prospective, real-world, and observational FINE-REAL study doi.org/10.1093/ckj/...

Size-selective glomerular filtration as a hallmark of premature kidney ageing in nondiabetic individuals doi.org/10.1093/ckj/...

Comparative renal effects of angiotensin receptor neprilysin inhibitors and ACEi/ARB: a systematic review and meta-analysis doi.org/10.1093/ckj/...

From pathophysiology to novel approaches for obesity-associated hypertension doi.org/10.1093/ckj/...

From pathophysiology to novel approaches for obesity-associated hypertension doi.org/10.1093/ckj/...

Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease doi.org/10.1093/ckj/...

Effect of erythropoiesis-stimulating agent types on malignancy in hemodialysis patients doi.org/10.1093/ckj/...

Chronic Kidney Disease in Older Adults: Trends in Prevalence and Healthcare Service Quality from 2012 to 2018 doi.org/10.1093/ckj/...

The burden of acute kidney disease: an epidemiological review and importance of follow-up care doi.org/10.1093/ckj/...

Reducing CKD burden in Europe: first make the elephant apparent! doi.org/10.1093/ckj/...

Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients With Type 2 Diabetes and Advanced CKD: Kidney And Cardiovascular Outcomes in a Real-World Setting doi.org/10.1093/ckj/...

Short and long-term outcomes in oliguric and non-oliguric acute kidney injury in intensive care: a retrospective, post-hoc, bicentric study doi.org/10.1093/ckj/...

Trajectories of Urea‑to‑creatinine Ratio and Risk of Clinical Outcomes in Survivors of Acute Kidney Disease: A Population-based Study doi.org/10.1093/ckj/...

Interested in high impact and frequently cited articles in @ckj-era.bsky.social ? here is a collection - worth having a look 📖🛋️ High-Impact Articles from Clinical Kidney Journal (CKJ) url:https://academic.oup.com/ckj/pages/high-impact-research#google_vignette

And also: @ckj-era.bsky.social now has a sharing function for Bluesky 👍

Association between serum short-chain fatty acid levels and the risk of all-cause and cardiovascular disease mortality in Chinese patients undergoing maintenance hemodialysis: a retrospective cohort study doi.org/10.1093/ckj/...

🤩 CKJ Social Media Team Call! Are you interested in joining the CKJ Social Media Team? 👇 Just go to the link below and apply! www.era-online.org/membership/o...

Risk of Intradialytic Hypotension Among Different Antihypertensives in HD Patients doi.org/10.1093/ckj/... Use of beta-blockers & ACEI/ARBs had neutral effect on IDH risk while DHP-CCBs & alpha-blockers were associated with lower risks of IDH & might be considered for patients with IDH risk factors

A registry-based retrospective study comparing pre-dialysis care and early outcomes in native vs. transplant kidney failure doi.org/10.1093/ckj/...

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) doi.org/10.1093/ckj/...

Clinical management of peripheral arterial disease in chronic kidney disease—a comprehensive review from the European Renal Association CKD-MBD Working Group doi.org/10.1093/ckj/...

Association of serum phosphate levels and statin use with cardiovascular events in Japanese patients on chronic haemodialysis: a post-hoc analysis of the LANDMARK trial doi.org/10.1093/ckj/...

Stroke risk in ADPKD patients treated by dialysis: a retrospective study doi.org/10.1093/ckj/...

Ten tips on how to manage kidney health in migrants and refugees doi.org/10.1093/ckj/...

Only the Bluesky is the limit: ten tips for a trending #Skytorial doi.org/10.1093/ckj/...

Ha! Just noticed I have achieved a lifetime first: coauthored two papers in the May issue of @ckj-era.bsky.social Really loved writing this one: academic.oup.com/ckj/article/...

Dapagliflozin in non-diabetic CKD with low/high ACR - OPTIMISE CKD observational design Pretty flat GFR slopes? academic.oup.com/ckj/article/... on @ckj-era.bsky.social #NephSky #OpenAccess

Cytosorb is still searching for an indication 😏 Myoglobin clearance no better than high flux dialysis In @ckj-era.bsky.social academic.oup.com/ckj/article/... #NephSky

Occurrence and prognosis of chronic kidney disease in Denmark – a nationwide population-based cohort study doi.org/10.1093/ckj/...

The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease doi.org/10.1093/ckj/...

Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review doi.org/10.1093/ckj/...

Shared decision making: a personal view from two kidney doctors and a patient FREE access: doi.org/10.1093/ckj/...

Acute kidney injury and point-of-care ultrasound in liver cirrhosis: redefining hepatorenal syndrome doi.org/10.1093/ckj/...

Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD) doi.org/10.1093/ckj/...

Obinutuzumab is effective for the treatment of rituximab refractory PLA2R-associated membranous nephropathy doi.org/10.1093/ckj/...

The diagnosis of acute interstitial nephritis caused by infection versus antibiotic-induced interstitial nephritis: a narrative review doi.org/10.1093/ckj/...

Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study doi.org/10.1093/ckj/...

Ten tips on how to deal with calciphylaxis patients doi.org/10.1093/ckj/...

CKD-associated pruritus in haemodialysis: a road map for diagnosis and treatment doi.org/10.1093/ckj/...

Does nighttime hypertension predict long-term kidney outcomesin patients with IgA nephropathy? doi.org/10.1093/ckj/...

Inferior vena cava ultrasound and other techniques for assessment of intravascular and extravascular volume: an update doi.org/10.1093/ckj/...

Fatigue across different chronic kidney disease populations: experiences and needs of patients doi.org/10.1093/ckj/...

Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis doi.org/10.1093/ckj/...

The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial doi.org/10.1093/ckj/...

Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohort doi.org/10.1093/ckj/...

Clinical Management of Peripheral Arterial Disease in CKD doi.org/10.1093/ckj/... This comprehensive review i) outlines the epidemiology, aetiology & pathophysiology of PAD in CKD, ii) discusses the role of CKD-MBD in PAD & iii) highlights ongoing studies & the future therapeutic landscape